Figlin RA - Search Results

1

Hypoxia-inducible factor pathway genes predict survival in metastatic clear cell renal cell carcinoma.

Tamukong PK, Kuhlmann P, You S, Su S, Wang Y, Yoon S, Gong J, Figlin RA, Janes JL, Freedland SJ, Halabi S, Small EJ, Rini BI, Kim HL. Tamukong PK, et al. Among authors: figlin ra. Urol Oncol. 2022 Nov;40(11):495.e1-495.e10. doi: 10.1016/j.urolonc.2022.07.010. Epub 2022 Aug 13. Urol Oncol. 2022. PMID: 35973929

2

Cytoreductive surgery in the management of metastatic renal cell carcinoma: the UCLA experience.

Franklin JR, Figlin R, Rauch J, Gitlitz B, Belldegrun A. Franklin JR, et al. Semin Urol Oncol. 1996 Nov;14(4):230-6. Semin Urol Oncol. 1996. PMID: 8946623

3

Immunotherapy and gene therapy.

Gitlitz BJ, Belldegrun A, Figlin RA. Gitlitz BJ, et al. Among authors: figlin ra. Semin Urol Oncol. 1996 Nov;14(4):237-43. Semin Urol Oncol. 1996. PMID: 8946624 Review.

4

Vaccine and gene therapy of renal cell carcinoma.

Gitlitz BJ, Belldegrun AS, Figlin RA. Gitlitz BJ, et al. Among authors: figlin ra. Semin Urol Oncol. 2001 May;19(2):141-7. Semin Urol Oncol. 2001. PMID: 11354534 Review.

5

Collecting duct renal cell carcinoma: clinical study of a rare tumor.

Chao D, Zisman A, Pantuck AJ, Gitlitz BJ, Freedland SJ, Said JW, Figlin RA, Belldegrun AS. Chao D, et al. Among authors: figlin ra. J Urol. 2002 Jan;167(1):71-4. doi: 10.1016/s0022-5347(05)65385-2. J Urol. 2002. PMID: 11743278

6

Mathematical model to predict individual survival for patients with renal cell carcinoma.

Zisman A, Pantuck AJ, Dorey F, Chao DH, Gitlitz BJ, Moldawer N, Lazarovici D, deKernion JB, Figlin RA, Belldegrun AS. Zisman A, et al. Among authors: figlin ra. J Clin Oncol. 2002 Mar 1;20(5):1368-74. doi: 10.1200/JCO.2002.20.5.1368. J Clin Oncol. 2002. PMID: 11870181

7

Immune gene therapy for kidney cancer: the search for a magic trigger.

Kim HL, Belldegrun AS, Figlin RA. Kim HL, et al. Among authors: figlin ra. Mol Ther. 2003 Feb;7(2):153-4. doi: 10.1016/s1525-0016(02)00048-5. Mol Ther. 2003. PMID: 12597902 Free article. Review. No abstract available.

8

Paraneoplastic signs and symptoms of renal cell carcinoma: implications for prognosis.

Kim HL, Belldegrun AS, Freitas DG, Bui MH, Han KR, Dorey FJ, Figlin RA. Kim HL, et al. Among authors: figlin ra. J Urol. 2003 Nov;170(5):1742-6. doi: 10.1097/01.ju.0000092764.81308.6a. J Urol. 2003. PMID: 14532767

9

Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population.

Han KR, Bleumer I, Pantuck AJ, Kim HL, Dorey FJ, Janzen NK, Zisman A, Dinney CP, Wood CG, Swanson DA, Said JW, Figlin RA, Mulders PF, Belldegrun AS. Han KR, et al. Among authors: figlin ra. J Urol. 2003 Dec;170(6 Pt 1):2221-4. doi: 10.1097/01.ju.0000096049.64863.a1. J Urol. 2003. PMID: 14634383

10

Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease.

Janzen NK, Kim HL, Figlin RA, Belldegrun AS. Janzen NK, et al. Among authors: figlin ra. Urol Clin North Am. 2003 Nov;30(4):843-52. doi: 10.1016/s0094-0143(03)00056-9. Urol Clin North Am. 2003. PMID: 14680319 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

381 results

Search Page